The article reflects on the correlation between loss of bone mass and sarcopenia with aging. It states that pharmaceutical companies are developing drugs targeting musculoskeletal system which reduces the risk of fracture. It further states that the Romanian FRAX model uses a fixed threshold for therapeutic intervention and diagnosis of osteoporosis.